Organon publishes post-market study of JADA PPH control system
The study showed that JADA could control bleeding in both vaginal and caesarean birth, regardless of the cause of the bleeding.
15 September 2023
15 September 2023
The study showed that JADA could control bleeding in both vaginal and caesarean birth, regardless of the cause of the bleeding.
Abcam founder Jonathan Milner has declared his intention to vote against the acquisition of the company in which he holds a large stake.
The new apparatus and method provide positioning and guidance for patients at the time of upper-extremity rehabilitation.
The study was done in partnership with the UK’s National Health Service and included continuous glucose monitoring for participants.
The Signatera test is intended for several cancer types and indications.
The device features six electrodes and an integrated accelerometer for measuring head movement and body position.
Avenova Allograft is suitable for delicate ophthalmic applications.
Abbott Medical recall Proclaim systems and Infinity IPGs following reports of patients unable to exit MRI mode.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Generative AI can improve personalized healthcare by collecting data from patients via wearable devices, which can provide continuous, real-time data that can complement traditional data sources such as imaging, patient records, and more. It can also enhance existing imaging techniques by generating high-quality images of organs using data from low-resolution images (such as ultrasounds). However, the collection and use of patient healthcare data through AI medical products could conflict with regulations around the globe.
Give your business an edge with our leading industry insights.